Penobscot Investment Management Company, Inc. Bristol Myers Squibb CO Transaction History
Penobscot Investment Management Company, Inc.
- $1.06 Billion
- Q3 2024
A detailed history of Penobscot Investment Management Company, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Penobscot Investment Management Company, Inc. holds 15,128 shares of BMY stock, worth $873,793. This represents 0.07% of its overall portfolio holdings.
Number of Shares
15,128
Previous 15,204
0.5%
Holding current value
$873,793
Previous $631,000
23.93%
% of portfolio
0.07%
Previous 0.06%
Shares
18 transactions
Others Institutions Holding BMY
# of Institutions
2,536Shares Held
1.47BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.9 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.16 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.37 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.5 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.53 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $123B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...